Quarterly report [Sections 13 or 15(d)]

Consolidated Balance Sheet (Parenthetical)

v3.25.3
Consolidated Balance Sheet (Parenthetical) - USD ($)
$ in Millions
Sep. 30, 2025
Dec. 31, 2024
Assets    
Federal funds sold and securities borrowed or purchased under agreements to resell measured at fair value $ 173,686 $ 144,501
Trading account assets, pledged as collateral 174,783 170,328
Debt securities:    
Fair Value 446,544 450,548
Loans and leases, measured at fair value 6,694 4,249
Loans held for sale, measured at fair value 2,071 2,214
Other assets 9,830 13,176
Deposits in U.S. offices:    
Interest bearing, measured at fair value 1,079 310
Federal funds purchased and securities loans or sold under agreements to repurchase, at fair value 215,376 192,859
Short-term borrowings, measured at fair value 6,432 6,245
Accrued expenses and other liabilities, measured at fair value 8,511 13,199
Accrued expenses and other liabilities, reserve for unfunded lending commitments 1,109 1,096
Long-term debt, measured at fair value $ 66,315 $ 50,005
Shareholders’ equity    
Preferred stock, par value (in dollars per share) $ 0.01 $ 0.01
Preferred stock authorized (in shares) 100,000,000 100,000,000
Preferred stock issued (in shares) 3,991,164 3,877,917
Preferred stock outstanding (in shares) 3,991,164 3,877,917
Common stock, par value (in dollars per share) $ 0.01 $ 0.01
Common stock authorized (in shares) 12,800,000,000 12,800,000,000
Common stock issued (in shares) 7,329,421,929 7,610,862,311
Common stock outstanding (in shares) 7,329,421,929 7,610,862,311
Short-term debt $ 54,200 $ 43,391
Long-term debt 311,484 283,279
Consolidated VIEs    
Shareholders’ equity    
Short-term debt 4,980 3,329
Long-term debt 8,420 8,457
All other liabilities 22 21
Consolidated VIEs | Nonrecourse    
Shareholders’ equity    
Short-term debt 0 0
Long-term debt 8,420 8,457
All other liabilities $ 22 $ 21